Clinical Trials
381 trialsTesting the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
National Institutes of Health Clinical Center (CC)
Clinical Genetics Branch Eligibility Screening Survey
National Institutes of Health Clinical Center (CC)
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
National Institutes of Health Clinical Center (CC)
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
National Institutes of Health Clinical Center (CC)
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
National Institutes of Health Clinical Center (CC)
Collection of Tissue Samples for Cancer Research
National Institutes of Health Clinical Center (CC)
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
National Institutes of Health Clinical Center (CC)
Collection of Blood and Urine From Patients Undergoing Radiation Therapy
National Institutes of Health Clinical Center (CC)
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
National Institutes of Health Clinical Center (CC)
Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial
National Institutes of Health Clinical Center (CC)
Nutrition Intervention Trials in Linxian Follow-up Study
National Institutes of Health Clinical Center (CC)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
Gulf Long-Term Follow-Up Study
National Institutes of Health Clinical Center (CC)
Clinical and Genetic Studies of Li-Fraumeni Syndrome
National Institutes of Health Clinical Center (CC)
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Developing the Family Map: Looking at Communal Coping
National Institutes of Health Clinical Center (CC)
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
National Institutes of Health Clinical Center (CC)
Tumor Related Epilepsy
National Institutes of Health Clinical Center (CC)
Sample Collection and Tracking for the Developmental Therapeutics Clinic
National Institutes of Health Clinical Center (CC)
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Patient-Centered Assessment of Symptoms and Outcomes
National Institutes of Health Clinical Center (CC)
M7824 Related Adverse Effects in Adults With Cancer
National Institutes of Health Clinical Center (CC)
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
National Institutes of Health Clinical Center (CC)
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
National Institutes of Health Clinical Center (CC)
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
National Institutes of Health Clinical Center (CC)
Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
National Institutes of Health Clinical Center (CC)
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
National Institutes of Health Clinical Center (CC)
A Natural History Study of Metabolic Sizing in Health and Disease
National Institutes of Health Clinical Center (CC)
Data Collection, Clinical Care and Interventions in CCR, NCI
National Institutes of Health Clinical Center (CC)
NIH-AARP Diet and Health Secondary Research Study Based on OH95CN025 Data
National Institutes of Health Clinical Center (CC)
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
National Cancer Institute (NCI)
Connect for Cancer Prevention Study (Connect)
National Institutes of Health Clinical Center (CC)
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
National Institutes of Health Clinical Center (CC)
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
National Institutes of Health Clinical Center (CC)
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
National Institutes of Health Clinical Center (CC)
Harvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
National Institutes of Health Clinical Center (CC)
Agriculture Health Study
National Institutes of Health Clinical Center (CC)
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
National Institutes of Health Clinical Center (CC)
Case-Control Study of Pesticides and Childhood Leukemia
National Institutes of Health Clinical Center (CC)
Family Genetics Health Education and Healthy Behaviors
National Institutes of Health Clinical Center (CC)
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors
National Institutes of Health Clinical Center (CC)
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
National Institutes of Health Clinical Center (CC)
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Longitudinal Studies of Patient With FPDMM
National Institutes of Health Clinical Center (CC)
Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
National Institutes of Health Clinical Center (CC)